|
cardioplegia solutions
|
B05XA16 |
|
|
potassium lactate
|
B05XA15 |
|
|
potassium acetate
|
B05XA17 |
|
|
protionamide
|
J04AD01 |
|
|
tiocarlide
|
J04AD02 |
|
|
Other blood products
|
B05AX |
|
|
glucose
|
V04CA02 |
|
|
protein hydrolysates
|
B05BA04 |
|
|
ethionamide
|
J04AD03 |
|
|
carbohydrates
|
B05BA03 |
|
|
fat emulsions
|
B05BA02 |
|
|
tolbutamide
|
V04CA01 |
|
|
metipranolol and thiazides, combinations
|
C07BA68 |
|
|
Solutions for parenteral nutrition
|
B05BA |
|
|
phenazone, combinations excl. psycholeptics
|
N02BB51 |
|
|
Solutions affecting the electrolyte balance
|
B05BB |
|
|
metamizole sodium, combinations excl. psycholeptics
|
N02BB52 |
|
|
aminophenazone, combinations excl. psycholeptics
|
N02BB53 |
|
|
propyphenazone, combinations excl. psycholeptics
|
N02BB54 |
|
|
Antifungals for systemic use
|
D01BA |
|
